Liu, Naiqi
Zheng, Xinya
Zhang, Ruinan
Zhao, Zhuo
Cai, Xueli
Zhang, Anqi
Li, Shan
Wang, Yongjun https://orcid.org/0000-0002-9976-2341
Pan, Yuesong https://orcid.org/0000-0003-3082-6789
Clinical trials referenced in this document:
Documents that mention this clinical trial
Association of socioeconomic status with intracranial arterial plaque: mediated by cardiometabolic risk factors
https://doi.org/10.1136/svn-2025-004457
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases
https://doi.org/10.1136/svn-2022-001625
Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study
https://doi.org/10.1136/svn-2022-002191
PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)—a population-based prospective cohort study: rationale, design and baseline participant characteristics
https://doi.org/10.1136/svn-2020-000411
Epidemiological study of calcified aortic valve stenosis in a Chinese community population
https://doi.org/10.1136/pmj-2022-141721
Insulin resistance based on postglucose load measure is associated with prevalence and burden of cerebral small vessel disease
https://doi.org/10.1136/bmjdrc-2022-002897
Funding for this research was provided by:
Beijing High-level Public Health Technical Personnel Construction Project (Discipline leader -03-12)
Outstanding Young Talents Project of Capital Medical University (A2105)
Beijing Municipal Natural Science Foundation (QY24327)
the National Key R&D Program of China (No. 2022YFC3602500, 2022YFC3602505, 2024YFC3044800)
Zhejiang Provincial Medical and Health Key Science and Technology Program (WKJ-ZJ-2327)
Key Science & Technologies R&D Program of Lishui City (2023ZDYF17)
Capital Medical University "Undergraduate Scientific Research Innovation” project (XSKY2024390)
AstraZeneca Investment (China) Co., Ltd. (Grant no- NA)